Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus A Horwitz

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Mbio|June 1, 2022
<i>Listeria</i>-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c MiceQingmei Jia, Saša Masleša-Galić, Susana Nava, et al.
Infection and Immunity|July 26, 2005
Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory proteinMarcus A Horwitz, Günter Harth, Barbara Jane Dillon, et al.
Infection and Immunity|June 21, 2017
Listeria-Vectored Vaccine Expressing the Mycobacterium tuberculosis 30-Kilodalton Major Secretory Protein via the Constitutively Active <i>prfA</i>* Regulon Boosts Mycobacterium bovis BCG Efficacy against TuberculosisQingmei Jia, Barbara Jane Dillon, Saša Masleša-Galić, et al.
Vaccine|November 15, 2008
Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosisMarcus A Horwitz, Günter Harth, Barbara Jane Dillon, et al.
Molecular Microbiology|November 3, 2005
All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasisGünter Harth, Sasa Maslesa-Galić, Michael V Tullius, et al.
Accounts of Chemical Research|May 15, 2019
Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug DeliveryWei Chen, Carlotta A Glackin, Marcus A Horwitz, et al.
Vaccine|November 1, 2005
A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCGMarcus A Horwitz, Günter Harth, Barbara Jane Dillon, et al.
Vaccine|August 30, 2005
Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunityMarcus A Horwitz, Günter Harth, Barbara Jane Dillon, et al.
Infection and Immunity|February 27, 2013
A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challengeQingmei Jia, Richard Bowen, Jacob Sahakian, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2007
Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosisGünter Harth, Paul C Zamecnik, David Tabatadze, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Mbio|June 1, 2022
<i>Listeria</i>-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c MiceQingmei Jia, Saša Masleša-Galić, Susana Nava, et al.
Infection and Immunity|July 26, 2005
Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory proteinMarcus A Horwitz, Günter Harth, Barbara Jane Dillon, et al.
Infection and Immunity|June 21, 2017
Listeria-Vectored Vaccine Expressing the Mycobacterium tuberculosis 30-Kilodalton Major Secretory Protein via the Constitutively Active <i>prfA</i>* Regulon Boosts Mycobacterium bovis BCG Efficacy against TuberculosisQingmei Jia, Barbara Jane Dillon, Saša Masleša-Galić, et al.
Vaccine|November 15, 2008
Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosisMarcus A Horwitz, Günter Harth, Barbara Jane Dillon, et al.
Molecular Microbiology|November 3, 2005
All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasisGünter Harth, Sasa Maslesa-Galić, Michael V Tullius, et al.
Accounts of Chemical Research|May 15, 2019
Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug DeliveryWei Chen, Carlotta A Glackin, Marcus A Horwitz, et al.
Vaccine|November 1, 2005
A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCGMarcus A Horwitz, Günter Harth, Barbara Jane Dillon, et al.
Vaccine|August 30, 2005
Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunityMarcus A Horwitz, Günter Harth, Barbara Jane Dillon, et al.
Infection and Immunity|February 27, 2013
A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challengeQingmei Jia, Richard Bowen, Jacob Sahakian, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2007
Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosisGünter Harth, Paul C Zamecnik, David Tabatadze, et al.
Pageof 8